# AiMedRes Legal & Risk Assessment Template

## Purpose
This document provides a comprehensive framework for assessing legal, regulatory, and risk considerations before deploying AiMedRes in a healthcare environment.

---

## 1. Regulatory Compliance Assessment

### HIPAA Compliance (United States)

#### Privacy Rule Requirements
- [ ] Is Protected Health Information (PHI) being processed? **YES / NO**
- [ ] Have minimum necessary standards been applied?
- [ ] Is a Notice of Privacy Practices in place?
- [ ] Are patient authorization forms required and available?
- [ ] Have workforce training requirements been met?

#### Security Rule Requirements
- [ ] Has a comprehensive risk assessment been completed?
- [ ] Are administrative safeguards implemented?
  - [ ] Security Management Process
  - [ ] Assigned Security Responsibility
  - [ ] Workforce Security
  - [ ] Information Access Management
  - [ ] Security Awareness and Training
  - [ ] Security Incident Procedures
  - [ ] Contingency Planning
  - [ ] Business Associate Contracts
- [ ] Are physical safeguards implemented?
  - [ ] Facility Access Controls
  - [ ] Workstation Use and Security
  - [ ] Device and Media Controls
- [ ] Are technical safeguards implemented?
  - [ ] Access Control
  - [ ] Audit Controls
  - [ ] Integrity Controls
  - [ ] Transmission Security

#### Breach Notification Rule
- [ ] Breach notification procedures documented
- [ ] Incident response plan in place
- [ ] Breach risk assessment methodology defined
- [ ] Notification templates prepared (individuals, HHS, media)

#### Business Associate Agreement (BAA)
- [ ] BAA required? **YES / NO**
- [ ] BAA template reviewed by legal counsel
- [ ] BAA executed with all applicable parties
- [ ] Subcontractor BAAs in place (if applicable)

---

### GDPR Compliance (European Union)

#### Applicability
- [ ] Is EU resident data being processed? **YES / NO**
- [ ] Is the organization established in the EU?
- [ ] Are goods/services offered to EU residents?

#### Legal Basis for Processing
- [ ] Legal basis identified (check applicable):
  - [ ] Consent
  - [ ] Contract
  - [ ] Legal obligation
  - [ ] Vital interests
  - [ ] Public task
  - [ ] Legitimate interests

#### Data Subject Rights
- [ ] Procedures for Right to Access implemented
- [ ] Procedures for Right to Rectification implemented
- [ ] Procedures for Right to Erasure ("Right to be Forgotten") implemented
- [ ] Procedures for Right to Restriction of Processing implemented
- [ ] Procedures for Right to Data Portability implemented
- [ ] Procedures for Right to Object implemented
- [ ] Automated decision-making safeguards in place

#### Data Processing Agreement (DPA)
- [ ] DPA required? **YES / NO**
- [ ] DPA template compliant with GDPR Article 28
- [ ] DPA executed with all processors
- [ ] Data transfer mechanisms documented (if data leaves EU)

#### Data Protection Impact Assessment (DPIA)
- [ ] DPIA required? **YES / NO**
- [ ] DPIA completed and documented
- [ ] High-risk processing identified and mitigated
- [ ] DPO consulted (if applicable)

#### Data Protection Officer (DPO)
- [ ] DPO required? **YES / NO**
- [ ] DPO appointed and contact details published
- [ ] DPO involved in all data protection matters

---

### FDA Regulations (United States)

#### Software as a Medical Device (SaMD) Classification
- [ ] Is AiMedRes a medical device under FDA definition? **YES / NO / UNCERTAIN**
- [ ] Device classification determined: **Class I / Class II / Class III / Not a Device**
- [ ] Clinical Decision Support (CDS) exemption applicable? **YES / NO**

#### 21 CFR Part 11 (Electronic Records/Signatures)
- [ ] Electronic records used? **YES / NO**
- [ ] Electronic signatures used? **YES / NO**
- [ ] System validation documentation prepared
- [ ] Audit trail capabilities implemented
- [ ] System access controls implemented

#### Quality System Regulation (QSR) / Quality Management System (QMS)
- [ ] Design controls implemented (if Class II/III device)
- [ ] Risk management process established (ISO 14971)
- [ ] Post-market surveillance plan in place
- [ ] Complaint handling procedures documented

#### Premarket Submission Requirements
- [ ] Premarket notification (510(k)) required? **YES / NO**
- [ ] Premarket approval (PMA) required? **YES / NO**
- [ ] De Novo classification requested? **YES / NO**
- [ ] Submission prepared and filed (if applicable)

---

### Other Regulatory Considerations

#### State/Provincial Regulations
- [ ] State-specific healthcare IT regulations reviewed
- [ ] Telemedicine/telehealth regulations reviewed (if applicable)
- [ ] Professional licensing requirements reviewed
- [ ] State breach notification laws reviewed

#### International Standards
- [ ] ISO 13485 (Medical Devices QMS) compliance assessed
- [ ] ISO 27001 (Information Security) certification pursued/planned
- [ ] ISO 14971 (Risk Management) applied to medical devices
- [ ] IEC 62304 (Medical Device Software Lifecycle) followed

#### Institutional Review Board (IRB)
- [ ] IRB approval required for intended use? **YES / NO**
- [ ] Research protocol submitted and approved
- [ ] Informed consent process established
- [ ] Continuing review scheduled

---

## 2. Legal & Contractual Review

### Intellectual Property
- [ ] Software license terms reviewed and acceptable
- [ ] Open source dependencies reviewed for license compatibility
- [ ] Patent search conducted (if applicable)
- [ ] Trademark usage reviewed and approved

### Liability & Insurance
- [ ] Professional liability coverage reviewed
- [ ] Cyber liability insurance in place
- [ ] Product liability coverage assessed (if medical device)
- [ ] Indemnification clauses reviewed by legal counsel

### Contracts & Agreements
- [ ] End User License Agreement (EULA) reviewed
- [ ] Terms of Service reviewed and approved
- [ ] Service Level Agreement (SLA) negotiated
- [ ] Master Service Agreement (MSA) executed (if applicable)
- [ ] Data sharing agreements in place (if multi-site)

### Employment & Workforce
- [ ] Confidentiality agreements signed by all staff
- [ ] Background checks completed per institutional policy
- [ ] Role-based access agreements documented
- [ ] Acceptable use policies acknowledged

---

## 3. Risk Assessment & Mitigation

### Risk Assessment Methodology
- [ ] Risk assessment framework selected: ________________________
- [ ] Risk scoring criteria defined (likelihood Ã— impact)
- [ ] Risk tolerance levels established
- [ ] Risk register created and maintained

### Clinical Risk Assessment

#### Patient Safety Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| CR-01 | Incorrect diagnosis/prediction due to model error | | | | | | |
| CR-02 | Delay in care due to system downtime | | | | | | |
| CR-03 | Misinterpretation of AI output by clinician | | | | | | |
| CR-04 | Patient data shown to wrong clinician | | | | | | |
| CR-05 | Failure to detect critical condition | | | | | | |

#### Clinical Workflow Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| CW-01 | Workflow disruption during implementation | | | | | | |
| CW-02 | User resistance/low adoption | | | | | | |
| CW-03 | Insufficient training leading to errors | | | | | | |
| CW-04 | Alert fatigue from excessive notifications | | | | | | |

### Technical Risk Assessment

#### System Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| TR-01 | Data loss due to hardware failure | | | | | | |
| TR-02 | System breach/unauthorized access | | | | | | |
| TR-03 | Integration failure with EMR/EHR | | | | | | |
| TR-04 | Performance degradation under load | | | | | | |
| TR-05 | Model drift over time reducing accuracy | | | | | | |

#### Data Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| DR-01 | PHI exposure/data breach | | | | | | |
| DR-02 | Data corruption during transfer | | | | | | |
| DR-03 | Inadequate data quality affecting predictions | | | | | | |
| DR-04 | Data retention violations | | | | | | |

### Compliance & Legal Risks

#### Regulatory Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| LR-01 | HIPAA violation and penalties | | | | | | |
| LR-02 | GDPR violation and fines | | | | | | |
| LR-03 | FDA enforcement action | | | | | | |
| LR-04 | State regulatory action | | | | | | |

#### Liability Risks
| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| LI-01 | Malpractice claim related to AI output | | | | | | |
| LI-02 | Contract breach with vendor/partner | | | | | | |
| LI-03 | Intellectual property infringement | | | | | | |

### Operational Risks

| Risk ID | Risk Description | Likelihood | Impact | Risk Score | Mitigation Strategy | Owner | Status |
|---------|------------------|------------|--------|------------|---------------------|-------|--------|
| OR-01 | Insufficient support staff/expertise | | | | | | |
| OR-02 | Budget overruns | | | | | | |
| OR-03 | Project delays affecting go-live | | | | | | |
| OR-04 | Vendor/third-party dependency | | | | | | |

---

## 4. Ethical & Bias Considerations

### AI Ethics Assessment
- [ ] Algorithmic bias assessment completed
- [ ] Fairness across demographic groups evaluated
- [ ] Transparency and explainability requirements defined
- [ ] Patient autonomy and informed consent addressed
- [ ] Clinician override capability implemented

### Bias & Fairness Testing
- [ ] Training data demographics documented
- [ ] Performance disparities across subgroups assessed
- [ ] Mitigation strategies for identified biases implemented
- [ ] Ongoing monitoring for bias drift established

### Ethical Review
- [ ] Ethics committee review conducted (if applicable)
- [ ] Ethical guidelines for AI use documented
- [ ] Patient advocacy groups consulted
- [ ] Transparency in AI decision-making ensured

---

## 5. Incident Response Planning

### Security Incident Response
- [ ] Incident response team identified
- [ ] Incident classification system defined
- [ ] Escalation procedures documented
- [ ] Communication templates prepared
- [ ] Forensic investigation procedures established

### Breach Notification Procedures
- [ ] Breach assessment criteria defined (HIPAA 4-factor test)
- [ ] Notification timelines documented (individuals, regulators, media)
- [ ] Notification templates prepared
- [ ] Legal counsel involvement procedures established

### Clinical Safety Incident Response
- [ ] Adverse event reporting procedures defined
- [ ] Root cause analysis process established
- [ ] Corrective and preventive action (CAPA) procedures documented
- [ ] Regulatory reporting requirements identified

---

## 6. Audit & Compliance Monitoring

### Audit Requirements
- [ ] Internal audit schedule established
- [ ] External audit requirements identified (e.g., HITRUST, SOC 2)
- [ ] Audit trail requirements implemented
- [ ] Log retention policies defined

### Compliance Monitoring
- [ ] Key compliance metrics identified
- [ ] Monitoring dashboard or reporting established
- [ ] Compliance review cadence defined (monthly, quarterly)
- [ ] Remediation procedures for non-compliance established

---

## 7. Sign-Off & Approvals

### Legal Review
- [ ] Reviewed by Legal Counsel: ___________________________  Date: _______
- [ ] Comments/Concerns: ________________________________________________

### Compliance Review
- [ ] Reviewed by Compliance Officer: ___________________________  Date: _______
- [ ] Comments/Concerns: ________________________________________________

### Privacy Review
- [ ] Reviewed by Privacy Officer/DPO: ___________________________  Date: _______
- [ ] Comments/Concerns: ________________________________________________

### Clinical Review
- [ ] Reviewed by Clinical Leadership: ___________________________  Date: _______
- [ ] Comments/Concerns: ________________________________________________

### Risk Management Review
- [ ] Reviewed by Risk Manager: ___________________________  Date: _______
- [ ] Comments/Concerns: ________________________________________________

### Final Approval
- [ ] **APPROVED** - Proceed with deployment
- [ ] **CONDITIONAL APPROVAL** - Proceed with conditions (document below)
- [ ] **NOT APPROVED** - Address issues before proceeding

**Conditions/Actions Required (if applicable):**
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________

**Final Approver**: ___________________________  
**Title**: ___________________________  
**Date**: ___________________________

---

## 8. Ongoing Review & Updates

### Review Schedule
- [ ] Quarterly legal and compliance review scheduled
- [ ] Annual comprehensive risk assessment scheduled
- [ ] Regulatory updates monitoring process established
- [ ] Incident-driven reviews documented

### Document Control
**Document Version**: 1.0  
**Created By**: ___________________________  
**Creation Date**: ___________________________  
**Last Reviewed**: ___________________________  
**Next Review Date**: ___________________________

---

## Appendix: Supporting Documentation

List all supporting documents and their locations:

1. Privacy Impact Assessment (DPIA): ___________________________
2. Risk Register (detailed): ___________________________
3. Business Associate Agreements: ___________________________
4. Data Processing Agreements: ___________________________
5. FDA Submission (if applicable): ___________________________
6. IRB Approval (if applicable): ___________________________
7. Insurance Certificates: ___________________________
8. Audit Reports: ___________________________
9. Training Records: ___________________________
10. Incident Response Plan: ___________________________

---

**Notes:**  
This template should be customized for your specific institution, jurisdiction, and use case. Consult with qualified legal counsel, compliance professionals, and risk management experts throughout the assessment process.
